Fidelity Disruptive Medicine ETF (FMED)

Assets	$53.87M
Expense Ratio	0.50%
PE Ratio	41.67
Shares Out	2.12M
Dividend (ttm)	$0.11
Dividend Yield	0.45%
Ex-Dividend Date	Dec 20, 2024
Payout Ratio	18.60%
1-Year Return	+5.67%

Volume	4,382
Open	25.45
Previous Close	25.39
Day's Range	25.32 - 25.46
52-Week Low	23.32
52-Week High	26.68
Beta	n/a
Holdings	61
Inception Date	Apr 16, 2020

About FMED

Fund Home Page

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is issued by Fidelity.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NASDAQ
• Ticker Symbol: FMED
• ETF Provider: Fidelity

Top 10 Holdings

44.18% of assets

Name	Symbol	Weight
Boston Scientific Corporation	BSX	7.13%
Fidelity Securities Lending Cash Central Fund	n/a	7.09%
Intuitive Surgical, Inc.	ISRG	5.00%
Insulet Corporation	PODD	4.67%
UnitedHealth Group Incorporated	UNH	4.05%
Danaher Corporation	DHR	3.85%
argenx SE	ARGX	3.59%
Penumbra, Inc.	PEN	3.03%
Waystar Holding Corp.	WAY	2.93%
Exact Sciences Corporation	EXAS	2.84%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 20, 2024	$0.112	n/a
Jun 21, 2024	$0.001	Jun 25, 2024